Author:
Baribeau Danielle A.,Anagnostou Evdokia
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference95 articles.
1. Center for Disease Control and Prevention. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012;61(3):1–19.
2. Coury DL, Anagnostou E, Manning-Courtney P, Reynolds A, Cole L, McCoy R, et al. Use of psychotropic medication in children and adolescents with autism spectrum disorders. Pediatrics. 2012;130 Suppl 2:S69–76. doi: 10.1542/peds.2012-0900D .
3. Jesner OS, Aref-Adib M, Coren E. Risperidone for autism spectrum disorder. Cochrane Database Syst Rev. 2007;(1):CD005040. doi: 10.1002/14651858.CD005040.pub2 .
4. McDougle CJ, Holmes JP, Carlson DC, Pelton GH, Cohen DJ, Price LH. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry. 1998;55(7):633–41.
5. RUPP, McCracken JT, McGough J, Shah B, Cronin P, Hong D, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347(5):314–21.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献